| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McBee Brannin | Chief Development Officer | C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON | /s/ Nisha Antony, as Attorney-in-Fact | 14 Jan 2026 | 0002058103 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRWV | Class A Common Stock | Conversion of derivative security | +25,000 | 25,000 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F1, F2 | |||
| transaction | CRWV | Class A Common Stock | Sale | $10,995 | -140 | -0.56% | $78.53 | 24,860 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F4 |
| transaction | CRWV | Class A Common Stock | Sale | $40,736 | -512 | -2.1% | $79.56 | 24,348 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F5 |
| transaction | CRWV | Class A Common Stock | Sale | $8,710 | -108 | -0.44% | $80.65 | 24,240 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F6 |
| transaction | CRWV | Class A Common Stock | Sale | $8,931 | -109 | -0.45% | $81.94 | 24,131 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F7 |
| transaction | CRWV | Class A Common Stock | Sale | $12,827 | -155 | -0.64% | $82.76 | 23,976 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F8 |
| transaction | CRWV | Class A Common Stock | Sale | $65,222 | -776 | -3.2% | $84.05 | 23,200 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F9 |
| transaction | CRWV | Class A Common Stock | Sale | $20,474 | -240 | -1% | $85.31 | 22,960 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $74,912 | -868 | -3.8% | $86.30 | 22,092 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $125,955 | -1,446 | -6.5% | $87.11 | 20,646 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F12 |
| transaction | CRWV | Class A Common Stock | Sale | $321,803 | -3,648 | -18% | $88.21 | 16,998 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F13 |
| transaction | CRWV | Class A Common Stock | Sale | $646,165 | -7,254 | -43% | $89.08 | 9,744 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F14 |
| transaction | CRWV | Class A Common Stock | Sale | $466,638 | -5,182 | -53% | $90.05 | 4,562 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F15 |
| transaction | CRWV | Class A Common Stock | Sale | $386,560 | -4,240 | -93% | $91.17 | 322 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F16 |
| transaction | CRWV | Class A Common Stock | Sale | $29,540 | -322 | -100% | $91.74 | 0 | 12 Jan 2026 | Brannin J McBee 2022 Irrevocable Trust | F2, F3, F17 |
| transaction | CRWV | Class A Common Stock | Conversion of derivative security | +1,000 | 1,000 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F1, F18 | |||
| transaction | CRWV | Class A Common Stock | Sale | $2,917 | -37 | -3.7% | $78.84 | 963 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F19 |
| transaction | CRWV | Class A Common Stock | Sale | $1,459 | -18 | -1.9% | $81.08 | 945 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18 |
| transaction | CRWV | Class A Common Stock | Sale | $3,027 | -36 | -3.8% | $84.09 | 909 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F20 |
| transaction | CRWV | Class A Common Stock | Sale | $4,740 | -55 | -6.1% | $86.19 | 854 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F21 |
| transaction | CRWV | Class A Common Stock | Sale | $11,158 | -127 | -15% | $87.86 | 727 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F22 |
| transaction | CRWV | Class A Common Stock | Sale | $26,316 | -296 | -41% | $88.90 | 431 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F23 |
| transaction | CRWV | Class A Common Stock | Sale | $20,764 | -231 | -54% | $89.89 | 200 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F24 |
| transaction | CRWV | Class A Common Stock | Sale | $16,581 | -182 | -91% | $91.10 | 18 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18, F25 |
| transaction | CRWV | Class A Common Stock | Sale | $1,654 | -18 | -100% | $91.87 | 0 | 12 Jan 2026 | Canis Major 2025 Family Trust LLC | F3, F18 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRWV | Class B Common Stock | Conversion of derivative security | -25,000 | -0.61% | 4,091,020 | 12 Jan 2026 | Class A Common Stock | 25,000 | Brannin J. McBee 2022 Irrevocable Trust | F1, F2 | |||
| transaction | CRWV | Class B Common Stock | Conversion of derivative security | -1,000 | -0.87% | 113,600 | 12 Jan 2026 | Class A Common Stock | 1,000 | Canis Major 2025 Family Trust LLC | F1, F18 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. |
| F2 | The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee. |
| F3 | The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.94 to $78.88, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.14 to $80.09, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.21 to $80.99, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.39 to $82.19, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.51 to $83.10, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.57 to $84.47, inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.56, inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.60 to $86.59, inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.61 to $87.59, inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.63 to $88.62, inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.63 to $89.62, inclusive. |
| F15 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.63 to $90.56, inclusive. |
| F16 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.65 to $91.63, inclusive. |
| F17 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.66 to $91.85, inclusive. |
| F18 | The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. |
| F19 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.54 to $79.12, inclusive. |
| F20 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.18 inclusive. |
| F21 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.63 to $86.47, inclusive. |
| F22 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.38 to $88.29, inclusive. |
| F23 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.40 to $89.27, inclusive. |
| F24 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.46 to $90.31, inclusive. |
| F25 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.58 to $91.33, inclusive. |
This Form 4 is Part 2 of 4 for this reporting person. Transactions by the reporting person are continued on Parts 3 and 4.